Biomarkers for Alzheimer’s Disease Drug Development /
| Autor Corporativo: | |
|---|---|
| Otros Autores: | |
| Formato: | eBook |
| Lenguaje: | English |
| Publicado: |
New York, NY :
Springer New York : Imprint: Humana,
2018.
|
| Edición: | 1st ed. 2018. |
| Colección: | Methods in Molecular Biology,
1750 |
| Materias: |
Tabla de Contenidos:
- Epidemiology of Dementia: The Burden on Society, the Challenges for Research
- Population-based Approaches to Alzheimer’s Disease Prevention
- Systems Biology Methods for Alzheimer’s Disease Research towards Molecular Signatures, Subtypes and Stages and Precision Medicine. Application in Cohort Studies and Trials
- CSF Lipidomics Analysis: High-Resolution Mass Spectrometry Analytical Platform
- CSF N-glycomics using MALDI MS Techniques in Alzheimer’s Disease
- MicroRNA Profiling of Alzheimer’s Disease Cerebrospinal Fluid
- Validation of a Chemiluminescence Immunoassay for Measuring Amyloid-β in Human Blood Plasma
- Mass Spectrometry-based Metabolomic Multiplatform for Alzheimer’s Disease Research
- Blood-based Biomarker Screening with Agnostic Biological Definitions for an Accurate Diagnosis within the Dimensional Spectrum of Neurodegenerative Diseases
- Functional Magnetic Resonance Imaging in Alzheimer’ Disease Drug Development
- Neuroimaging Methods for MRI Analysis in CSF Biomarkers Studies
- Hybrid PET-MRI in Alzheimer’s Disease Research
- Amyloid PET Imaging: Standardization and Integration with Other Alzheimer Disease Biomarkers
- The use of 18F-FDG PET in the Diagnostic Workup of Alzheimer’s Dementia
- Quantification of Tau Load in Alzheimer’s Disease Clinical Trials Using Positron Emission Tomography
- Imaging Neuroinflammation: Quantification of Astrocytosis in a Multitracer PET Approach
- Unbiased Lipidomics and Metabolomics of Human Brain Samples
- Neuropathological Assessment as an Endpoint in Clinical Trial Design
- Analysis of micro-RNA Expression by qPCR on a Microfluidics Platform for Alzheimer’s Disease Biomarker Discovery
- Telomere length shortening in Alzheimer’s disease – procedures for a causal investigation using single nucleotide polymorphisms in a Mendelian Randomization study
- Quantifying miRNA Deregulation in Alzheimer’s Disease
- Imaging of Microglial Activation in Alzheimer’s Disease by [11C]PBR28 PET
- In Vivo Two-photon Calcium Imaging of Hippocampal Neurons in Alzheimer Mouse Models
- Cognitive Assessment in Alzheimer’s Disease Clinical Trials
- Data Mining and Machine Learning Methods for Dementia Research. .